2 employees
Satoris develops tests for neurological diseases such as Alzheimer's, Parkinson's, Multiple Sclerosis, and Diabetic Neuropathy.
2003
$5.2M
from 2 investors over 2 rounds
Satoris Inc. raised $5.2M on March 25, 2008
Investors: Diergaarde Blijdorp Rotterdam (Zoo) and Life Science Angels